about
Genotyping Parkinson disease-associated mitochondrial polymorphismOxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometryPossibility of selection against mtDNA mutations in tumors.Pesticides and Parkinson's disease--is there a link?Mitochondrial biology and Parkinson's diseaseA Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure.The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutantsEstablishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal DiabetesA high-throughput screen for mitochondrial function reveals known and novel mitochondrial toxicants in a library of environmental agentsIntracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomaliesMitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifyingThe PINK1/Parkin pathway regulates mitochondrial morphologyThe Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in DrosophilaRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changesMitochondrial cell death control in familial Parkinson disease.The mitochondrial fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathwayColonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder.Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease.Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's diseaseA comparative proteomic strategy for subcellular proteome research: ICAT approach coupled with bioinformatics prediction to ascertain rat liver mitochondrial proteins and indication of mitochondrial localization for catalase.Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease.Translocation and potential neurological effects of fine and ultrafine particles a critical update.Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.Mitochondrial avid radioprobes. Preparation and evaluation of 7'(Z)-[125I]iodorotenone and 7'(Z)-[125I]iodorotenol.Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.Inflammation as a causative factor in the aetiology of Parkinson's diseaseHydrogen sulfide as an endogenous modulator in mitochondria and mitochondria dysfunction.Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionFrequencies of mtDNA mutations in primary tissues of colorectal adenopolyps.Nmnat delays axonal degeneration caused by mitochondrial and oxidative stressThe effects of pyridaben pesticide on the histomorphometric, hormonal alternations and reproductive functions of BALB/c mice.The effects of pyridaben pesticide on the DNA integrity of sperms and early in vitro embryonic development in mice.Mitochondrial Profile and Responses to TGF-β Ligands in Keratoconus.Molecular Effects of L-dopa Therapy in Parkinson's Disease.Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.Underlying role of mitochondrial mutagenesis in the pathogenesis of a disease and current approaches for translational research.Occupational pesticide use and Parkinson's disease in the Parkinson Environment Gene (PEG) study.Anti-Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves
P2860
Q23924039-2238807D-2F69-4899-A8D5-C481B0F74B92Q24307861-DEF4F28E-DA2E-4434-B6C2-BDD088611148Q24815938-99F26087-254D-4A62-9D4E-792AE6CE1FD4Q25257240-D319A209-3E89-48F7-95C4-511B977C0E82Q26824090-CC984B13-2021-4050-B559-44A2CF0E96E0Q27308753-A7898F9F-9240-4407-A5AA-FC7922CEE5E2Q27335187-8A6B1ED4-8F30-4C9F-BC57-08FC6B580CA6Q28354148-07547F27-8C21-4685-BC64-6CF2BC11E3DEQ28394079-D0DE1F9A-8CB9-4694-AD26-1F3A4B422AF7Q28397133-FF100582-F518-4CB4-906D-17FDA5898F3DQ28732683-56C86C12-5F99-4E77-BED3-280B3CE9E658Q29615641-39471773-3569-4863-99A3-B227D4131CE3Q29617091-5BBFA589-0C64-4868-BE2F-34494821384AQ30446460-46586055-57D2-4754-8893-217BDA23D685Q30497542-16E74546-73BB-4345-9E02-17ADFB0F2D0EQ33291145-A592255E-5516-40F1-BF92-6DF37C0C2CCDQ33552320-580D6CBA-FD9D-4834-B04B-E246562A0CB9Q33808959-865D6818-810D-4D21-B23C-CC6AD7F19DE9Q33841155-A6962C29-53E6-4ADE-99E6-DC798FBD0362Q33868426-5309789F-CDDF-4762-AC34-273024DA8058Q33906098-B647F1B7-FF78-4AF2-9944-64681DEE4E7AQ34362301-52841002-E9B2-4052-87E9-69BA48CA1826Q34722724-4D6F3163-9110-453C-90DF-F493B6157E63Q35040112-3ACAFF3A-AFBA-4133-977F-6078EA08BF2CQ35065682-CAF041E4-6535-477E-BC52-5BA5551FB0ABQ35752002-1F669968-9A83-4F4C-86B9-9C73AEB96965Q35917625-DB7ABE91-07AE-4032-95EB-4F5BC63E4B59Q36052641-17A5278C-6C97-4938-A14C-11D7ABFF2959Q36469123-614E88D7-8757-4DD9-8962-826434D77018Q36919403-81910CFE-0D96-47BF-9846-44C0B135C6BAQ37084540-1FE9D9FD-5E44-4604-A537-922C93CCFEC5Q37183202-BC375B14-C42E-4618-A63D-22C0EC299206Q37416826-89BBC59E-FD69-4986-802F-CF026DD668DAQ37615436-62F7C8FC-CA1E-424F-B048-CF7866846BA2Q37652773-8E52CFA9-ACF8-484B-8EBA-152D370D0183Q38346832-6AC9F9AA-12E2-4A3F-B6FC-5139879859E7Q38733729-5C4F24C4-6C59-4F8E-ABBF-EDCA8E33729DQ39000027-181205BB-00C9-456E-BF49-519334AE10ACQ40093722-B278D8B2-9C9A-4A2E-B13E-4EB6D74B5E3AQ41981198-B4B8C7D7-D9BA-40EF-8CC9-66918E6FF8A1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Environment, mitochondria, and Parkinson's disease.
@ast
Environment, mitochondria, and Parkinson's disease.
@en
Environment, mitochondria, and Parkinson's disease.
@nl
type
label
Environment, mitochondria, and Parkinson's disease.
@ast
Environment, mitochondria, and Parkinson's disease.
@en
Environment, mitochondria, and Parkinson's disease.
@nl
prefLabel
Environment, mitochondria, and Parkinson's disease.
@ast
Environment, mitochondria, and Parkinson's disease.
@en
Environment, mitochondria, and Parkinson's disease.
@nl
P2093
P2860
P1433
P1476
Environment, mitochondria, and Parkinson's disease.
@en
P2093
J Timothy Greenamyre
Ranjita Betarbet
Todd B Sherer
P2860
P304
P356
10.1177/1073858402008003004
P577
2002-06-01T00:00:00Z